Publication:
Activity and damage in granulomatosis with polyangiitis

dc.contributor.authorDİRESKENELİ, RAFİ HANER
dc.contributor.authorTUĞLULAR, ZÜBEYDE SERHAN
dc.contributor.authorsYegin, Ender G.; Can, Meryem; Yilmaz, Neslihan; Aydin, Sibel Z.; Yavuz, Sule; Tuglular, Serhan; Direskeneli, Haner
dc.date.accessioned2022-03-12T18:08:44Z
dc.date.accessioned2026-01-10T16:52:24Z
dc.date.available2022-03-12T18:08:44Z
dc.date.issued2013
dc.description.abstractAim To retrospectively analyze disease activity and damage-associated factors in granulomatosis with polyangiitis (GPA) in Turkey. Method A retrospective analysis was carried out in 21 GPA patients. Assessments for activity were performed with the Birmingham Vasculitis Activity Score for GPA (BVAS/GPA) and for permanent organ damage by the Vasculitis Damage Index (VDI). Results Lower BVAS/GPA (P=0.002), absence of renal involvement (P=0.003) and higher creatinine clearence (P=0.000) at diagnosis increased the likelihood of achieving remission at 6weeks. Relapses were associated with high creatinine clearence (P=0.021), low BVAS/GPA (P=0.014), absence of renal involvement (P=0.036) and proteinuria (<0.5/24h) (P=0.013) at diagnosis, whereas achieving remission at 6weeks (P=0.012) was associated with absence of co-trimoxazole usage (P=0.038) and less severe clinical subgroup (P=0.034). Lower cumulative first 6months of cyclophosphamide and methylprednisolone were associated with earlier (12months) relapses (P=0.048 and P=0.083, respectively). Baseline damage (VDI1) was associated with a delay in diagnosis (P=0.032), presentation with milder clinical subgroups (P=0.052) and low serum creatinine (P=0.013). The increase in VDI in the first 12months (early damage) constituted most (91%) of the total damage measured at the end of follow-up. Conclusions Despite high early remission rates, relapse represents a major problem in localized GPA in our study. Baseline damage was associated with longer diagnostic delay and lower baseline serum creatinine. The initial phase of the disease seems to be the most crucial period for mortality and accumulated damage.
dc.identifier.doi10.1111/1756-185x.12022
dc.identifier.eissn1756-185X
dc.identifier.issn1756-1841
dc.identifier.pubmed23441774
dc.identifier.urihttps://hdl.handle.net/11424/231192
dc.identifier.wosWOS:000315489700011
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectactivity
dc.subjectdamage
dc.subjectgranulomatosis with polyangiitis
dc.subjectWEGENERS-GRANULOMATOSIS
dc.subjectMICROSCOPIC POLYANGIITIS
dc.subjectSYSTEMIC VASCULITIS
dc.subjectPULSE CYCLOPHOSPHAMIDE
dc.subjectPROGNOSTIC-FACTORS
dc.subjectRANDOMIZED-TRIAL
dc.subjectPLASMA-EXCHANGE
dc.subjectRELAPSE
dc.subjectINDEX
dc.subjectPREDICTORS
dc.titleActivity and damage in granulomatosis with polyangiitis
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage71
oaire.citation.issue1
oaire.citation.startPage61
oaire.citation.titleINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
oaire.citation.volume16

Files